Full name
APTEKA ESKULAP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
20 - Manufacture of chemicals and chemical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46 - Wholesale trade
47 - Retail trade
73 - Advertising, market research and public relations
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0 | 0 | -0,1 | -1032,7 |
Gross profit (loss) | -0 | -0 | -0,1 | -269,8 |
EBITDA | -0 | 86,2 | ||
Short time liabilities | 1,1 | 1,1 | 1,3 | 15,8 |
Other operating costs | 0 | 0 | 0 | 27,3 |
Equity capital | -0,5 | -0,5 | -0,6 | -20,4 |
Operating profit (EBIT) | -0 | -0 | -0,1 | -273,9 |
Assets | 0,6 | 0,6 | 0,7 | 12 |
Net profit (loss) | -0 | -0 | -0,1 | -269,8 |
Cash | 0 | 0,1 | 0 | -27,5 |
Net income from sale | 2,2 | 2,3 | 2,3 | -2,2 |
Liabilities and provisions for liabilities | 1,1 | 1,1 | 1,3 | 15,8 |
Working assets | 0,6 | 0,6 | 0,7 | 12 |
Other income costs | 0 | 0 | 0 | -38,4 |
Depreciation | 0 | 0 | ||
% | % | % | p.p. | |
Profitability of capital | 7,1 | 5,5 | 17 | 11,5 |
Equity capital to total assets | -77,7 | -80,6 | -86,6 | -6 |
Gross profit margin | -1,5 | -1,2 | -4,4 | -3,2 |
EBITDA Margin | -0,6 | 3,5 | ||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 173 | 173 | 204 | 31 |
Current financial liquidity indicator | 0.5626876950263977 | 0.5538373589515686 | 0.5358979105949402 | -0,1 |
Net dept to EBITDA | 2.9290199279785156 | 2,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane